Triple substituted phenanthroline derivatives for the treatment of neurodegenerative diseases or conditions or blood diseases or conditions, or cancer

摘要

The present invention relates to a new family of triple substituted phenantroline derivatives of formula (I), which are useful for the treatment or profilaxis of a neurodegenerative or haematological disease or condition, their use as a medicament, especially for treating a neurodegenerative or haematological disease or condition, and a pharmaceutical composition comprising the compounds.